Clinical Variability in Spinal Muscular Atrophy Type III
Year: 2020
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: We report natural history data in a large cohort of 199 patients with spinal muscular atrophy (SMA) type III assessed using the Hammersmith Functional Motor Scale Expanded (HFMSE). The aim of the study was to establish the annual rate and possible patterns of progression according to a number of variables, such as age of onset, age at assessment, SMN2 copy number, and functional status. METHODS: HFMSE longitudinal changes were assessed using piecewise linear mixed-effects models. The dependency in the data due to repeated measures was accounted for by a random intercept per individual and an unstructured covariance R matrix was used as correlation structure. An additional descriptive analysis was performed for 123 patients, for a total of 375 12-month assessments. RESULTS: A break point at age 7 years was set for the whole cohort and for SMA IIIA and IIIB. Age, SMA type, and ambulatory status were significantly associated with changes in mean HFMSE score, whereas gender and SMN2 copy number were not. The increase in response before the break point of age 7 years is significant only for SMA IIIA (β = 1.79, p < 0.0001). After the break point, the change in the rate of HFMSE score significantly decrease for both SMA IIIA (β = -1.15, p < 0.0001) and IIIB (β = -0.69, p = 0.002). INTERPRETATION: Our findings contribute to the understanding of the natural history of SMA type III and will be helpful in the interpretation of the real-world data of patients treated with commercially available drugs. ANN NEUROL 2020;88:1109-1117.
Source: Annals of Neurology
DOI: 10.1002/ana.25900
Authors: Giorgia Coratti, Sonia Messina, Simona Lucibello, Maria Carmela Pera, Jacqueline Montes, Amy Pasternak, Francesca Bovis, Jessica Exposito Escudero, Elena Stacy Mazzone, Anna Mayhew, Allan M. Glanzman, Sally Dunaway Young, Rachel Salazar, Tina Duong, Robert Muni Lofra, Roberto De Sanctis, Sara Carnicella, Evelin Milev, Matthew Civitello, Marika Pane, Mariacristina Scoto, Chiara Marini Bettolo, Laura Antonaci, Annalia Frongia, Maria Sframeli, Gian Luca Vita, Adele D'Amico, Marleen Van Den Hauwe, Emilio Albamonte, Nathalie Goemans, Basil T. Darras, Enrico Bertini, Valeria Sansone, John Day, Andres Nascimento Osorio, Claudio Bruno, Francesco Muntoni, Darryl C. De Vivo, Richard S. Finkel, Eugenio Mercuri
Institutions: Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Centro Clinico Nemo, University of Messina, Columbia University Irving Medical Center, Boston Children's Hospital, Harvard University, University of Genoa, Hospital Sant Joan de Déu Barcelona, Instituto de Salud Carlos III, Centre for Biomedical Network Research on Rare Diseases, Institut de Recerca Sant Joan de Déu, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle University, Children's Hospital of Philadelphia, Stanford Medicine, Stanford University, Great Ormond Street Hospital, University College London, St. Jude Children's Research Hospital, Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Universitair Ziekenhuis Leuven, University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Istituto Giannina Gaslini, NIHR Great Ormond Street Hospital Biomedical Research Centre
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: G3934481036
OpenAlex ID: W3086583873
